Evidence map›Paper›PMID 34445327›Full record

ArticleInternational journal of molecular sciences2021

Silver Nanoparticles Derived by

Valentina Bordoni, Luca Sanna, Weidong Lyu, Elisabetta Avitabile, Stefano Zoroddu, Serenella Medici, David J Kelvin, Luigi Bagella

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Metal and Metal Oxide Nanoparticles UsingPlants (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Nutraceuticals in Pregnancy: A Special Focus on Probiotics.International journal of molecular sciences · 2024
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. 2-DimensionalFrontiers in bioengineering and biotechnology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 4 countries.

Valentina BordoniDepartment of Biomedical Sciences, University of Sassari, Viale San Pietro 43/b, 07100 Sassari, Italy.
Luca SannaDepartment of Biomedical Sciences, University of Sassari, Viale San Pietro 43/b, 07100 Sassari, Italy.
Weidong LyuDepartment of Biomedical Sciences, University of Sassari, Viale San Pietro 43/b, 07100 Sassari, Italy.
Elisabetta AvitabileDepartment of Biomedical Sciences, University of Sassari, Viale San Pietro 43/b, 07100 Sassari, Italy.
Stefano ZorodduDepartment of Biomedical Sciences, University of Sassari, Viale San Pietro 43/b, 07100 Sassari, Italy.
Serenella MediciDepartment of Chemistry and Pharmacy, University of Sassari, Via Muroni 23, 07100 Sassari, Italy.ORCID 0000-0002-4304-0251
David J KelvinDivision of Immunology, International Institute of Infection and Immunity, Shantou University Medical College, Shantou 515011, China.
Luigi BagellaDepartment of Biomedical Sciences, University of Sassari, Viale San Pietro 43/b, 07100 Sassari, Italy.ORCID 0000-0003-2815-037X
University of Sassari · ITDalhousie University · CA

Funding

Dalhousie University Dalhousie Medical Research FoundationShantou University Medical College Li Ka-Shing Foundation and International Institute of Infection and ImmunityUniversità degli Studi di Sassari Fondo di Ateneo per la Ricerca 2019Università degli Studi di Sassari P.O.R. F.S.E. 2014-2020
6 · The paper itself

Abstract

The fight against cancer is one of the main challenges for medical research. Recently, nanotechnology has made significant progress, providing possibilities for developing innovative nanomaterials to overcome the common limitations of current therapies. In this context, silver nanoparticles (AgNPs) represent a promising nano-tool able to offer interesting applications for cancer research. Following this path, we combined the silver proprieties with

Indexed as

Antineoplastic AgentsMetal NanoparticlesSilverApoptosisArtemisiaCell SurvivalDrug Screening Assays, AntitumorGene Expression Regulation, NeoplasticGreen Chemistry TechnologyHeLa CellsHumansMCF-7 CellsPC-3 CellsPlant ExtractsAntineoplastic AgentsPlant ExtractsSilverArtemisia arborescenscancer researchnanotechnologyRNA-seqsilver nanoparticles

Identifiers

PMID34445327
PMCPMC8395306
OpenAlexW3188127597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.